Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection
10.7759/cureus.41297
Saved in:
Main Authors: | Khan, Behram A, Pagsinohin, Marlyn, Lu, Lucy M, Tan, Pauline, Teo, Rachel |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Article |
Published: |
Springer Science and Business Media LLC
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/243068 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore.
by: Khan, Behram Ali
Published: (2023) -
A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit.
by: Khan, Behram Ali
Published: (2023) -
PHARMACOKINETICS OF CEFAZOLIN IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) AND HEMODIALYSIS PATIENTS
by: KAMANI GOPALAKRISHNA
Published: (2019) -
Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients
by: L. Ong-Ajyooth, et al.
Published: (2018) -
Salivary microbiome in patients undergoing hemodialysis and its associations with the duration of the dialysis
by: Xiaobo Duan, et al.
Published: (2020)